Compare HSBC Holdings plc (HSBC) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HSBC Holdings plc vs Novartis AG — how do they compare? HSBC Holdings plc trades at $101.09 (market cap $335.21B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: HSBC Holdings plc is the larger of the two by market cap, and HSBC Holdings plc pays the higher dividend (3.79%). Which is the better fit depends on your goals.
| HSBC | NVS | |
|---|---|---|
Market Cap | $335.21B | $290.25B |
Sector | Technology | Health |
52-Week High | $100.61 | $168.62 |
52-Week Low | $61.30 | $113.50 |
Dividend Yield | 3.79% | 3.17% |
Enterprise Value | — | $330.27B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
